48 completed, 5 unknown, 3 not yet recruiting, 2 active not recruiting. 61 Phase 1, 9 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 61 | Completed 48, Unknown 5, Not yet recruiting 3, Active not recruiting 2, Recruiting 2, Terminated 1 |
| Phase 2 | 9 | Completed 6, Active not recruiting 1, Terminated 1, Unknown 1 |
Follow Prostatic Hyperplasia: new trials by email Literature Review of Prostatic Hyperplasia trials Research Report on Prostatic Hyperplasia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trial to Evaluate the Bioequivalence of AD-116A Compared to AD-1161 in Healthy Adult Male Volunteers AD-116A, AD-1161 - Benign Prostatic Hyperplasia | Phase 1 | Not yet recruiting | Addpharma Inc. | 44 | 2026-07-01 | 2026-07-20 |
| A Clinical Trial to Evaluate the Bioequivalence of AD-116A and AD-1161 Under Fed Conditions in Healthy Adult Male Volunteers AD-116A, AD-1161 - Benign Prostatic Hyperplasia | Phase 1 | Not yet recruiting | Addpharma Inc. | 44 | 2026-07-01 | 2026-07-27 |
| Tadalafil 5 mg on Storage Lower Urinary Tract Symptoms After Anatomical Endoscopic Enucleation of the Prostate Tadalafil 5mg (Male), Omiga 3 - BPH (Benign Prostatic Hyperplasia) | Phase 1 | Not yet recruiting | Assiut University | 40 | 2026-03-01 | 2026-03-12 |
| A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 in Healthy Adult Male Subjects AD-116, AD-1161 - Benign Prostatic Hyperplasia | Phase 1 | Recruiting | Addpharma Inc. | 44 | 2026-02-26 | 2026-03-03 |
| A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846 CKD-846, D091 - Benign Prostate Hypertrophy(BPH) | Phase 1 | Completed | Chong Kun Dang Pharmaceutical | 34 | 2026-02-23 | 2026-07-21 |
| A Clinical Trial to Evaluate the Safety and the Pharmacokinetics of AD-116 Compared to AD-1161 in Healthy Adult Male Volunteers AD-116, AD-1161 - Benign Prostatic Hyperplasia | Phase 1 | Completed | Addpharma Inc. | 44 | 2026-01-22 | 2026-07-28 |
| BOTOX Injection Technique for LUTS Due to BPH Botulinum Toxin Type A (BoNT-A) - Benign Prostatic Hyperplasia | Phase 1 | Completed | Benha University | 60 | 2025-10-01 | 2026-06-12 |
| RT-310 Safety and Feasibility BPH Study RT-310 - BPH (Benign Prostatic Hyperplasia) | Phase 1 / Phase 2 | Active not recruiting | Resurge Therapeutics Inc. | 20 | 2025-03-13 | 2026-10-30 |
| RT-310 Dose Escalation BPH Study RT-310 - BPH (Benign Prostatic Hyperplasia), Lower Urinary Tract Symptoms | Phase 1 | Active not recruiting | Resurge Therapeutics Inc. | 20 | 2024-04-19 | 2026-11-02 |
| A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846 CKD-846, D091 - Benign Prostate Hypertrophy(BPH) | Phase 1 | Completed | Chong Kun Dang Pharmaceutical | 31 | 2023-11-13 | 2026-01-14 |
| Effetivity of Dutasteride and Aloe Vera Extract Combination on Angiogenesis and Obstruction on Benign Prostatic Hyperplasia Aloevera + dutasteride, Dutasteride (0.5mg) - BPH (Benign Prostatic Hyperplasia) | Phase 1 | Recruiting | Universitas Diponegoro | 84 | 2023-07-01 | 2025-07-15 |
| A 3 Months Duration Interventional Study Comparing Hemodynamic Parameters Between Bolus and Fractionated Group. 0.5% Heavy Bupivacaine - Prostatic Hyperplasia, Benign | Phase 1 | Completed | National Academy of Medical Sciences, Nepal | 72 | 2022-10-01 | 2024-10-08 |
| Office Based Transperineal Laser Ablation for Benign Prostatic Hyperplasia HYPERPLASIA SoracteLite(TM) TPLA for BPH - Male Urogenital Diseases, Genital Diseases, Male | Phase 1 | Unknown | Urological Research Network, LLC | 20 | 2020-11-20 | 2023-01-26 |
| A Study to Evaluate Drug-drug Interactions Between BR9006-1 and BR9006-2 in Healthy Male Volunteers. BR9006-1, BR9006-2 - Benign Prostatic Hyperplasia (BPH), Overactive Bladder | Phase 1 | Completed | Boryung Pharmaceutical Co., Ltd | 36 | 2020-07-20 | 2020-10-28 |
| Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers Harnal-D Tab., Chong Kun Dang Tamsulosin HCl Tab. - Benign Prostatic Hyperplasia | Phase 1 | Completed | Chong Kun Dang Pharmaceutical | 30 | 2019-03-11 | 2020-01-30 |
| Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers After Meal Harnal-D Tab., Chong Kun Dang Tamsulosin HCl Tab. - Benign Prostatic Hyperplasia | Phase 1 | Completed | Chong Kun Dang Pharmaceutical | 30 | 2019-03-11 | 2020-01-30 |
| The Effect of Traditional Chinese Medicine on Benign Prostatic Hyperplasia VGH-BPH1, Placebo (Corn starch pill manufactured to mimic VGH-BPH1) - Benign Prostatic Hyperplasia | Phase 1 / Phase 2 | Completed | Taipei Veterans General Hospital, Taiwan | 23 | 2019-03-06 | 2020-04-13 |
| Pharmacokinetics and Safety/Tolerability of YY-201 in Comparison to Dutasteride and Tadalafil Dutasteride 0.5 mg, Tadalafil 5 mg, YY-201 - Benign Prostatic Hyperplasia | Phase 1 | Completed | Yuyu Pharma, Inc. | 36 | 2017-03-27 | 2017-11-24 |
| A Phase 1 Trial for Evaluation of the Safety, Pharmacokinetics, and [18F] Radiation Dosimetry of CTT1057 CTT1057, Prostatectomy - Prostate Cancer | Phase 1 | Completed | Cancer Targeted Technology | 20 | 2016-09-01 | 2017-11-06 |
| A Study to Investigate the Pharmacokinetic Drug Interactions Between Dutasteride and Tadalafil in Healthy Male Subjects Tadalafil, Dutasteride - Benign Prostate Hyperplasia | Phase 1 | Completed | Yuyu Pharma, Inc. | 28 | 2016-05-01 | 2017-04-04 |
Showing 20 of 61. Sign in to see all of them.
Lower Urinary Tract Symptoms (7) · Urinary Bladder, Overactive (6) · Erectile Dysfunction (4) · Urinary Bladder Neck Obstruction (3) · Prostatic Diseases (2) · Fasting (1) · Genital Diseases, Male (1) · Male Urogenital Diseases (1) · Nocturia (1) · Prostatic Neoplasms (1) · Prostatitis (1) · Urinary Incontinence (1)
Genital Diseases (61) · Urogenital Diseases (61) · Genital Diseases, Male (60) · Male Urogenital Diseases (60) · Prostatic Diseases (59) · Pathological Conditions, Signs and Symptoms (12) · Signs and Symptoms (12) · Urological Manifestations (12) · Female Urogenital Diseases (8) · Female Urogenital Diseases and Pregnancy Complications (8) · Urinary Bladder Diseases (8) · Urologic Diseases (8) · Lower Urinary Tract Symptoms (5) · Mental Disorders (4) · Sexual Dysfunction, Physiological (4)
Tamsulosin (14) · Dutasteride (13) · Tadalafil (7) · Solifenacin Succinate (3) · Botulinum Toxins, Type A (2) · 1-(6-ethoxy-5-(3-ethyl-6,7-dihydro-2-(2-methoxyethyl)-7-oxo-2H-pyrazolo(4,3-d)pyrimidin-5-yl)-3-pyridyl sulphonyl)-4-ethylpiperazine (1) · Embryo Implantation (1) · Ethanol (1) · Finasteride (1) · Lipectomy (1) · PRX302 (1) · Photochemotherapy (1) · Prostatectomy (1) · QLT0074 (1) · Sildenafil Citrate (1)
GlaxoSmithKline (13) · Chong Kun Dang Pharmaceutical (6) · Addpharma Inc. (4) · Hanmi Pharmaceutical Company Limited (3) · Jeil Pharmaceutical Co., Ltd. (3) · Boehringer Ingelheim (2) · Dongkook Pharmaceutical Co., Ltd. (2) · Resurge Therapeutics Inc. (2) · Yuyu Pharma, Inc. (2) · Allergan (1) · American Medical Systems (1) · Assiut University (1) · Astellas Pharma Europe B.V. (1) · Benha University (1) · Boryung Pharmaceutical Co., Ltd (1)
South Korea (18) · United States (14) · Australia (4) · Brazil (2) · Germany (2) · Russia (2) · Canada (1) · China (1) · Dominican Republic (1) · Egypt (1) · Indonesia (1) · Israel (1) · Japan (1) · Nepal (1) · Netherlands (1)
Kyung-sang Yu, M.D., Ph.D. (2) · Min Kyu Park, MD, PhD (2) · Minsu Park, M.D., Ph.D. (2) · Yu-Jung Cha (2) · An-Hye Kim (1) · Andrey A Pulin, MD, PhD (1) · Andrey Z Vinarov, MD, PhD, Prof (1) · Beatrice Langton-Webster, PhD (1) · Denis V Butnaru, MD, PhD (1) · Fernando Bianco, MD (1) · Georg Golor, PD Dr. med. (1)